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Upper gastrointestinal bleeding episodes from variceal structures are severe complications in patients with portal
hypertension. Endoscopic sclerotherapy and variceal ligation are the treatment options preferred for upper variceal
bleeding owing to extrahepatic portal hypertension due to portal vein thrombosis (PVT). Recurrent duodenal
variceal bleeding in non-cirrhotic patients with diffuse porto-splenic vein thrombosis and subsequent portal
cavernous transformation represent a clinical challenge if classic shunt surgery is not possible or suitable.
In this study, we represent a case of recurrent bleeding of duodenal varices in a non-cirrhotic patient with
cavernous transformation of the portal vein that was successfully treated with a collateral caval shunt operation.
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Related to continuing improvements in endoscopic, inter-
ventional radiological and pharmacological treatment op-
tions, therapy strategies for cirrhotic and non-cirrhotic
patients suffering from portal hypertension-related com-
plications have undergone rapid change within the last
years [1,2].
Management of disease complications such as varices of
the gastrointestinal system plays an important role in ther-
apy progress [3,4].
Compared to gastric and esophageal varices, duodenal
varices are rarely found in patients with (extra-) hepatic
portal hypertension due to portal vein thrombosis (PVT).
Therefore, in this patient base, bleeding complications often
entail much more serious and fatal consequences [5,6].
Endoscopic sclerotherapy and endoscopic variceal
ligation replaced open surgical portosystemic shunt op-
erations as first-line treatment modalities in patients* Correspondence: peter.fellmer@medizin.uni-leipzig.de
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unless otherwise stated.with upper gastrointestinal variceal bleedings related to
portal hypertension [1-4,7]. Nevertheless, in case of endo-
scopic treatment failure (15% of cases in total), a portosys-
temic shunt operation represents the therapy option of
choice [1,2,4,5,8]. In these cases a surgical shunt procedure
was indicated for patients with a Child-Pugh A cirrhosis to
reduce the incidence of re-bleeding, maintain hepatic func-
tion and provide structural stability. In contrast, transjugu-
lar intrahepatic portosystemic shunts (TIPS) are indicated
for patients suffering from Child B/C cirrhosis and for
those scheduled for liver transplantation [1,9,10].
Besides treatment of variceal bleeding episodes, suffi-
cient management of thrombo-embolic complications of
the portal venous system is required in patients with
PVT suffering from portal hypertension [11]. In about
37% of these patients, PVT is associated with thrombosis
of splenic and superior mesenteric veins in combination
with a cavernous transformation of the portal vein, and
classical portosystemic shunt operations (spleno-renal,
porto-caval or mesenterico-caval) are not feasible and/or
suitable [12]. In this case, there is need for a different
treatment concept.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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episodes from duodenal varices are illustrated in a pa-
tient without cirrhosis but suffering from extrahepatic
portal hypertension caused by PVT. This case presents a
collateral caval shunt operation as an alternative therapy
option after failure of endoscopic procedures.
Case presentation
A 41-year-old male patient was admitted to hospital be-
cause of a circulatory collapse with hematemesis. Patient
was undergoing phenprocoumon therapy due to deep
vein thrombosis 5 years earlier and portal vein throm-
bosis caused by protein S deficiency 7 years earlier.
The initial basic examination’s result was normocytic
anemia and distinct tachycardia (120 beats per minute).
Blood analysis results showed: Hb 5.1 mmol/l (normal
range: 8.1 to 10.7 mmol/l); white blood cell count 3,500/uL
(normal range: 4,000 to 9,000/uL); platelet count 11.9 ×
104/UL (normal range: 11 to 40 × 104/uL); serum albumin
28.4 g/L (normal range: 35 to 52 g/L); prothrombin time
was 31%; and international normalized ratio was 3.91.
Emergency esophago-gastroduodenoscopy showed bloody
duodenal varices of about 1 cm diameter in the proximal
second portion of the duodenum. Bleeding was success-
fully treated by endoscopic sclerotherapy. Additionally, in
endoscopic examination one small esophageal and one
isolated gastric varice type I were detected. The patient
received blood transfusion with four units of packed red
blood cells. Abdominal sonography, as well as computed
tomography scan (CT), showed an extrahepatic PVT with
involvement/obstruction of the main portal vein including
the confluent, proximal part of the right portal branch,
suggesting involvement of the proximal part of the upper
mesenteric vein. In addition, a cavernous transformationCollateral vein 
paracaval 1.8 
cm
Figure 1 Preoperative computed tomography scan displaying a colla
(white arrow) due to portal hypertension caused by extrahepatic porof the portal vein with subsequent extrahepatic portal
hypertension was observed. However, there was a collat-
eral vein with approximately 1.8 cm diameter next to the
inferior caval vein (Figure 1).
Medical therapy was initiated by giving a beta-blocker
(propranolol 150 mg per day) to decrease pressure in the
portal venous system.
Two days after initial endoscopy, a re-endoscopy showed
one persisting nodular duodenal varice of about 0.5 to
1 cm diameter with recurrent variceal hemorrhage that
responded poorly to sclerotherapy (Figure 2). Another at-
tempt of interventional sclerotherapy in combination with
ligation was performed, but was not successful. Due to de-
creased hemoglobin value, the patient was transfused an-
other two units of packed red blood cells.
On the basis of failed endoscopic attempts to manage
bleeding and the long history of PVT with consecutive
cavernous transformation (to maybe pose a problem in
implementation of TIPS), we scheduled open surgical
treatment.
In the context of a distinct PVT with cavernous trans-
formation of the portal venous system and probable in-
ability to reduce pressure in the portal venous system (if
classical shunt procedures were to be performed, such as
spleno-renal, porto-caval or mesenterico-caval), we de-
cided to apply a different kind of technique.
Consequently, we performed a collateral caval shunt
operation with the inferior caval vein and a big collateral
vein adjacent to the inferior caval vein.
After laparotomy via a mid-transverse Mercedes-type
incision in the upper abdomen, a Kocher maneuver was
performed, and the caval vein was dissected in a circu-
lar shape. The next step repeated this same procedure
with the big collateral vein, and then, both vascularVena cava inferior
teral vein adjacent to the inferior caval vein 1.8 cm in diameter
tal vein thrombosis.
Figure 2 Endoscopic view of nodular varices in the proximal second portion of the duodenum.
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to-side anastomosis between the collateral vein and inferior
caval vein using PDS 4-0 suture.
The patient’s postoperative course was uneventful, and
no complications were observed. Doppler ultrasound
examination showed regular perfusion in the new anasto-
mosis and caval vein. Control endoscopy showed a notable
reduction of consistent duodenal varices 2 weeks after
surgical treatment. By the end of the follow-up periodFigure 3 Endoscopic view 12 months after the implementation of the(12 months), no further bleeding episodes were seen in
the patient. Endoscopic examination showed normal mu-
cosal structures in the duodenum (Figure 3). Collaterals
along the duodenum and portal vein had disappeared as
well, owing to a reduced portal pressure gradient.
Discussion
As far as we know, this is the first case report describ-
ing the treatment with a collateral caval shunt operationcollateral caval shunt with regular relations in the duodenum.
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cirrhotic patient suffering from portal hypertension and
PVT.
This report shows that implementation of a collateral
caval shunt might be one good alternative to re-establish
decompression in the portal venous system in patients
with cavernous transformation of the portal vein and re-
current duodenal variceal bleeding. In this case, we were
able to reach a rapid reduction of the pressure gradient
in the portal venous system by surgical intervention. By
the end of the follow-up period (12 months), a regular
structural situation could be observed in the duodenal sys-
tem. Additionally, peri- and postoperative complications
could not be observed and no further bleeding occurred.
Non-cirrhotic, non-tumoral PVT is the second most fre-
quent cause of portal hypertension in the world (5 to 10%).
In Asia, extrahepatic PVT is also a common cause for por-
tal hypertension and accountable for up to 30% of total
variceal bleeding in comparison to about 10% in the west-
ern world [9,12,13]. Etiology of PVT has changed over the
last years, accompanied with a variety of causes for non-
cirrhotic portal hypertension, such as prothrombotic or
thrombophilic disorders, neoplasm, inflammatory lesions
(pancreatitis, intra-abdominal sepsis, pylephlebitis of the
portal/umbilical veins etcetera) on the one hand, and exter-
nal and operative traumas, polycythemia vera or portal vein
obstruction/thrombosis on the other. (Table 1) [1,14].Table 1 Etiology of portal vein thrombosis modified from
Sobhonslidusk A [14] and Caronna [1]
Thrombophilic disorders Local factors
Inherited disorders Infections/inflammation
High risk of thrombosis (low prevalence): Neonatal omphalitis
Antithrombin III deficit Appendicitis
Protein C deficit Diverticulitis
Protein S deficit Pancreatitis
Cholecystitis
Low risk of thrombosis (high prevalence): Perforated peptic ulcer
Leiden V factor mutation Tuberculous lymphadenitis
Factor II mutation
Acquired disorders Portal vein injury
Malignancy Surgical shunts
Myeloproliferative disorders Splenectomy
Use of oral contraceptives Abdominal surgery
Antiphospholipid syndrome Liver transplants
Pregnancy and postpartum Blunt trauma
Paroxysmal nocturnal
Hemoglobinuria
Mixed disorders Cancer of the abdominal
organs Cirrhosis
HyperhomocysteinemiaIn most cases, non-cirrhotic patients with chronic
PVT do not show any symptoms. They usually first
present with complaints due to portal hypertension,
such as thrombocytopenia, anemia, splenomegaly or
variceal bleeding. In 20 to 55% of all cases, patients with
PVT are suffering from gastroesophageal varices [15,16].
Duodenal varices are quite rare and only occur in 0.4%
of all patients with portal hypertension [7].
There are different treatment options to manage com-
plications of non- cirrhotic patients suffering from chronic
PVTand portal hypertension, such as surgical intervention
in contrast to endoscopic and radiological interventions or
drug treatment. Besides standard endoscopic interven-
tions, new interventional radiological procedures like TIPS
will soon be in the spotlight as an approach for treatment
of patients with PVT and/or duodenal varices.
Although TIPS can be performed in patients with se-
vere liver dysfunction, one limitation of this therapy op-
tion is that in patients with severe liver atrophy, there is
an increased risk for complications such as hepatic en-
cephalopathy or cerebral embolization [7,17,18]. There-
fore, in combination with PVT, TIPS has been shown to
be successful only in a few cases. Case studies on TIPS are
often associated with patients suffering from portal bilio-
pathy and/or portal vein thrombosis or complicated Budd
Chiari Syndrome [19,20].
In their large case series of TIPS insertion, Senzalo et al.
reported on 28 patients suffering from PVT and portal
hypertension with a mean follow-up of 18.1 months.
Twenty-three of 28 patients showed complete PVT, and 9
of 23 showed cavernous transformation. Eleven of 28 pa-
tients suffered from non-cirrhotic portal vein thrombosis.
In 19 patients (73%), TIPS insertion was successful. Six pa-
tients underwent post-interventional stent revisions, three
underwent liver transplantation, and one died from bleed-
ing. Most cirrhotic patients showed a decreased CHILD
score [19]. Considering that, some other authors even
suggest PVT in combination with cavernous transform-
ation to be a contraindication for TIPS [21,22]. In our
case, after conferring with the radiological department,
we decided not to perform TIPS for the following rea-
sons: high age of the portal venous thrombus (7 years),
already existing total obstruction of the portal vein, in-
cluding the proximal part of the right branch, involve-
ment of the upper mesenteric vein, and increased risk
for the injury of hilar structures by tapping the portal
vein. However, TIPS might be an acceptable alternative
technique in treatment of selected patients suffering
from chronic PVT where the lumen of the thrombosed
portal vein is able to be catheterized and the caverno-
matous vein is to be dilatated [19].
In view of recent progress in minimally invasive tech-
niques, surgical procedures such as portosystemic shunt
operations are about to shrink in importance. Nevertheless,
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and permanent decompression of the portal venous system
in patients suffering from portal hypertension and extrahe-
patic PVT [9]. Finding the perfect type of shunting proced-
ure to treat patients with extrahepatic PVT in particular
has opened the floor for a long-term debate for the last
years. Splenorenal shunts (side-to-side or central) and
mesocaval shunts have been proved to be an effective tool
in management of bleeding episodes [23-25]. In a series,
Orloff et al. reported 200 patients suffering from portal
hypertension caused by PVT, partly treated with splenore-
nal (134 patients) and partly with mesocaval (66 patients)
shunts. Five patients (2.5%), each with a central end-to-side
splenorenal shunt, developed shunt thrombosis and had
recurrent variceal bleedings. The ten-year-survival rate was
97% versus a 15-year-survival rate of 95%. None of the pa-
tients developed any portal-systemic encephalopathy, and
all liver function tests (laboratory data, sonography and
angiography) were normal [24].
In this context, however, diffuse thrombosis of the en-
tire portal venous system, especially with subsequent de-
velopment of a cavernous transformation of the portal
vein, (portal cavernoma), represents a formidable chal-
lenge in patient treatment. Cavernoma usually appear a
few days after interruption of portal blood flow, consti-
tuting a compensatory mechanism via bypassing the
obstructed vein. They are built by portosystemic and
peri-/portoportal collaterals [3,12]. Unfortunately, there
are only a few case studies reporting some experience
with shunt surgery in cases of cavernous transformation
of the portal vein [26-28]. In his series, Zhang et al.
reported surgical treatment in 18 patients with portal
cavernous transformation. In 12 of 18 patients, there
was history of upper gastrointestinal bleeding, five suf-
fered from splenomegaly and hypersplenism, one suf-
fered from ascites, and six other patients had undergone
a ‘splenectomy and disconnection’ in other hospitals. In
eight patients a mesocaval shunt was performed, in two
patients a splenectomy and disconnection were per-
formed, in three patients a central splenorenal shunt was
performed, and in six patients a distal splenorenal shunt
operation was performed. There were no deaths or hep-
atic encephalopathy episodes after operation. After oper-
ation portal pressure was reduced significantly, bleeding
recurred in two patients (disconnection in one patient
and a mesocaval shunt in another one) [27].
However, in this case, we decided not to do a classical
shunt procedure like splenorenal or mesenterico-caval for
the following reasons: there was well-marked PVT with
cavernous transformation of the portal venous system and
we objected an involvement of the upper mesenteric vein’s
proximal part. In our opinion, the big collateral vein en-
abled better venous drainage of the portal venous system
with consequent achievement of better effects on theportal blood flow than in classical shunt types. Anatomic
shape and position of the collateral facilitated anastomiz-
ing and made us forego implementing splenorenal shunts.
Conclusions
Considering the results of this case and other reports,
implementation of a collateral caval shunt can be recom-
mended to patients with portal cavernous transformation
and recurrent duodenal varices in case classical shunt
operations are not suitable or are arguably very difficult
ordangerous. Nevertheless, existence of a collateral vein
with an acceptable size is an important condition for a
successful shunt implementation.
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